334
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Introduction: chronic pain studies of the lidocaine patch 5% using the neuropathic pain scale

Pages S1-S4 | Accepted 04 Oct 2004, Published online: 12 Nov 2004

References

  • Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959–64
  • Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin J Pain 2000;16:S118–S130
  • Fields HL, Rowbotham MC. Multiple mechanisms of neuropathic pain: a clinical perspective. In: Gebhart GF, Hammond DL, et al., editors. Proceedings of the 7th World Congress on Pain. Seattle: IASP Press; 1994. p. 437–54
  • Chung K, Lee BH, Yoon YW, Chung JM. Sympathetic sprouting in the dorsal root ganglia of the injured peripheral nerve in a rat neuropathic pain model. J Comp Neurol 1996;376:241–52
  • McLachlan EM, Janig W, Devor M, Michaelis M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993;363:543–6
  • Koestler AJ, Doleys DM. The psychology of pain. In: Satterthwaite JR, Tollison JW, editors. Practical pain management, 3rd ed. Philadelphia (PA): Lippincott, Williams, and Wilkins; 2002:26–39
  • Fordyce WE. Behavioral methods for chronic pain and illness. St. Louis (MO): Mosby; 1976
  • Sanders SH. Operant conditioning with chronic pain: back to basics. In: Turk DC, Gatchel RJ, editors. Psychological approaches to pain management: a practitioner’s handbook, 2nd ed. New York: Guilford Press; 2002. p. 128–37
  • Loeser JD, Turk DC. Multidisciplinary pain treatment. In: Loeser JD, Butler SH, et al., editors. Bonica’s management of pain, 3rd ed. Philadelphia (PA): Lippincott, Williams, and Wilkins; 2001. p. 2069–79
  • Richeimer SH, Macres SM. Psychological and medical complications of chronic pain management. Semin Anesth 1996;15:224–37
  • Comer AM, Lamb HM. Lidocaine patch 5%. Drugs 2000;59:245–9
  • Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60:1524–34
  • Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–38
  • Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277–99
  • Melzack R. The short-form McGill pain questionnaire. Pain 1987;30:191–7
  • Wilkie DJ, Keefe FJ, Dodd MJ, Copp LA. Behavior of patients with lung cancer: description and associations with oncologic and pain variables. Pain 1992;51:231–40
  • Lynch ME, Clark AJ, Sawynok J. Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design. Pain 2003;103:111–7
  • Plesh O, Curtis D, Levine J, McCall Jr WD. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil 2000;27:834–41
  • Tannock I, Gospodarowicz M, Meakin W, Panzarella T, Stewart L, Rider W. Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989;7:590–7
  • Wilkie DJ, Huang HY, Reilly N, Cain KC. Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors. J Pain Symptom Manage 2001;22:899–910
  • Masson EA, Hunt L, Gem JM, Boulton AJ. A novel approach to the diagnosis and assessment of symptomatic diabetic neuropathy. Pain 1989;38:25–8
  • Melzack R, Terrence C, Fromm G, Amsel R. Trigeminal neuralgia and atypical facial pain: use of the McGill Pain Questionnaire for discrimination and diagnosis. Pain 1986;27:297–302
  • Graff-Radford SB, Shaw LR, Naliboff BN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin J Pain 2000;16:188–92
  • Bellamy N, Campbell J, Syrotuik J. Comparative study of self-rating pain scales in osteoarthritis patients. Curr Med Res Opin 1999;15:113–9
  • Jenkinson C, Carroll D, Egerton M, Frankland T, McQuay H, Nagle C. Comparison of the sensitivity to change of long and short form pain measures. Qual Life Res 1995;4:353–7
  • Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147–57
  • Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain 2003;19:306–14
  • Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004;108:248–57
  • Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997;48:332–8
  • Galer BS, Gammaitoni AR, Oleka N, Jensen MP, Argoff CE. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin 2004;20\(Suppl 2):S5–S12
  • Gammaitoni AR, Galer BS, Onawola R, Jensen MP, Argoff CE. Lidocaine patch 5% positively impacts pain qualities in osteoarthritis: results of a 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 2004;20\(Suppl 2):S13–S19
  • Argoff CE, Galer BS, Jensen MP, Oleka N, Gammaitoni AR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the neuropathic pain scale. Curr Med Res Opin 2004;20\(Suppl 2):S21–S28

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.